The market presents significant opportunities driven by high demand for biologics and protein therapeutics, as well as ...

One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through changes in ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

When exposed to green light, the protein AR3 increases alkalinity in cells, disrupting cellular functions and causing ...

Archaerhodopsin 3 (AR3) is a microbial proton pump that increases alkalinity inside a cell when exposed to green light.

A revolution has occurred in the field of pharmaceutical development due to the development of drugs that target membrane proteins. It is estimated that one-third of currently available drugs target G ...

The Living Brain Project showed that live brain samples from patients undergoing deep brain stimulation revealed differences in RNA splicing and protein expression compared to postmortem brain tissue.

The baculovirus expression vector system (BEVS) provides a versatile platform for the expression of individual recombinant proteins as well as multimeric protein complexes, virus-like particles, ...